| . |
|
|
|
1Department of Internal Medicine, Hanyang University College of Medicine, Seoul; 2Department of Life Science, Postech Biotech Center, Pohang University of Science and Technology, Pohang, Korea |
| Bevacizumab plus FOLFIRI for advanced colorectal cancer patients that progressed after oxaliplatin and irinotecan based chemotherapy: a pilot study |
|
Kwon Choi |
|
. |
|
|
|
|
| Abstract |
|
. |
|